Hospital de Cruces-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2021

  1. Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study

    Targeted Oncology, Vol. 16, Núm. 4, pp. 485-492

2004

  1. Samario-153-Lexidronam (EDTMP) en el tratamiento de las metástasis óseas

    Revista de la Sociedad Espanola del Dolor, Vol. 11, Núm. 1, pp. 15-20

2002

  1. Usefulness of transdermal fentanyl in the management of nonmalignant chronic pain: A prospective, observational, multicenter study

    Pain Clinic, Vol. 14, Núm. 2, pp. 99-112